Bradmer Pharmaceuticals (GLX) Scheduled to Post Earnings on Tuesday

Bradmer Pharmaceuticals (TSE:GLXGet Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Tuesday, March 26th. Analysts expect the company to announce earnings of C$0.74 per share for the quarter.

Bradmer Pharmaceuticals Price Performance

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on GLX. Stifel Canada reissued a “buy” rating on shares of Bradmer Pharmaceuticals in a research report on Wednesday, March 13th. Atb Cap Markets reissued an “outperform” rating on shares of Bradmer Pharmaceuticals in a research report on Friday, December 15th.

Read Our Latest Research Report on GLX

Featured Articles

Earnings History for Bradmer Pharmaceuticals (TSE:GLX)

Receive News & Ratings for Bradmer Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bradmer Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.